Houman D. Hemmati

Mediprint Ophthalmics, Inc. engages in the development of contact lenses technologies that treats eye diseases. The company was founded by Kokila Doshi and Praful Doshi and is headquartered in San Diego, CA.

Trailhead Biosystems, Inc. develops cell therapies. Its program includes cancer immunotherapy, bone induction, neural fate space project, kidney and blood program. The company was founded by Jan Jensen in 2013 and is headquartered in Cleveland, OH.

Noveome Biotherapeutics, Inc. develops novel biotherapeutic products that restore cell communication and system homeostasis. Its proprietary technology platform, derived from human placental cells, provides an exciting new approach to tissue regeneration and repair in a wide range of medical conditions and offers hope, especially in patients with maladies. The company was founded in 2001 by George L. Sing and William J. Golden and is headquartered in Pittsburgh, PA.

Founded in 1999, Draper Fisher Jurvetson ePlanet Ventures (DFJ ePlanet), founded by Asad Jamal, in partnership with Draper Fisher Jurvetson is a global venture capital firm headquartered in Redwood City, California with additional offices in Singapore, Beijing, Shanghai, Hong Kong London Tokyo and Mumbai.

Founded in 2003, Griffen-Rose LLC is an independent research firm located in New York City. Griffen serves the small- and micro-cap sectors by producing research reports to institutional investors. They focus on companies in a broad range of sectors including: alternative/renewable energy technology, beverages, biotechnology and drug discovery, coal production/mining, consumer goods, financial services, industrial raw materials and infrastructural goods, infrastructure construction, industrial heavy machinery, metals production/mining, power generation/utilities and real estate.